	The Non-Coding Code: Silent Regulators of MEG3 and Let-7i-3p/5p in the Progression of Acute Lymphoblastic Leukemia. Asian Pac J Cancer Prev Shanyoor GJ, Kadhim AA, Al-Khafaji HMAH, Al-Saedi MKA, Mohammed MQ. PMID: 41945960 [PubMed - indexed for MEDLINE]
	DNA Alterations in the Upstream Region of Exon 1 of OSBPL10 in Northern Thai Patients with Diffuse Large B-Cell Lymphoma. Asian Pac J Cancer Prev Yimpak P, Tantiworawit A, Rattanathammethee T, Daroontum T, Aungsuchawan S, Bumroongkit K. PMID: 41945956 [PubMed - indexed for MEDLINE]
	The Interplay of PD-L1, Kynurenine Pathway, and Vitamin D Shapes an Immunosuppressive Microenvironment in Acute Myeloid Leukemia. Asian Pac J Cancer Prev Choudhary A, Ramesh R, Kar R, Narasimhan PB, Ganesan P, Dubashi B, Ng R, R S, Kayal S. PMID: 41945941 [PubMed - indexed for MEDLINE]
	Associations of CRP, PCT, NC, and NLR with Anti-Infective Effect on Patients with Hematological Malignancy and Pulmonary Infection. Clin Lab Su Y, An X, Zhang X, Li L, Zuo J, Ge S, Bian J. PMID: 41945751 [PubMed - indexed for MEDLINE]
	Enhanced Understanding of Procalcitonin Utilization as an Infection Biomarker in Non-Hodgkin's Lymphoma. Clin Lab Chen L, Wu Z, Chen N, Xin N, Huo R, Qiu S, Zhou Z, Cui Z, Xiao Z. PMID: 41945747 [PubMed - indexed for MEDLINE]
	NT-proBNP and hs-cTnT in Predicting the Incidence and Prognosis of Anthracycline-Caused Cardiovascular Toxicities in Non-Hodgkin's Lymphoma. Clin Lab Su G, Peng W, Chen Y, Lin Y, Chen J, Xiao Y, Cui Z, Xiao Z. PMID: 41945746 [PubMed - indexed for MEDLINE]
	Venetoclax-Based Regimens in Chronic Myelomonocytic Leukemia: A Systematic Review and Meta-Analysis. Acta Haematol Abdulgayoom M, Afana MS, Haj Saleh L, Manthiri AA, Aweer NA, Bakheet M, Al-Mashdali AF, Mohamed SF. PMID: 41945493 [PubMed - as supplied by publisher]
	Ten-color multicolor flow cytometry-based measurable residual disease at pre-transplantation predicts relapse of acute myeloid leukemia: a prospective study. Int J Hematol Tazoe K, Nakamae H, Makuuchi Y, Kuno M, Takakuwa T, Okamura H, Hirose A, Nakamae M, Nishimoto M, Nakashima Y, Miyagawa H, Hino M. PMID: 41944958 [PubMed - as supplied by publisher]
	Chronic lymphatic leukaemia in a worker with a long-term occupational exposure to petroleum product mixtures: a case report. Arh Hig Rada Toksikol Bu, Bu. PMID: 41944400 [PubMed - indexed for MEDLINE]
	Beyond age: Frailty-guided care in hematologic malignancies. Cancer Friend R, Johnson PC, Campbell D, Rosko AE, Lai C. PMID: 41944130 [PubMed - indexed for MEDLINE]
	Integrating Rapid Lymphoma Next-Generation Sequencing Panel-Based Testing into Routine Genomic Diagnostics. Ann Lab Med Shin S, Lee ST. PMID: 41943395 [PubMed - as supplied by publisher]
	Optimizing first-line therapy for double-expressor lymphoma: a systematic review and meta-analysis of novel agent-augmented R-CHOP regimens. Cancer Cell Int Zhang MY, Xiao F, Li ZH, Huang HH. PMID: 41943110 [PubMed - as supplied by publisher]
	Multiple presentations: a single pathology, primary central nervous system lymphoma (PCNSL). A multicenter study. J Neurooncol González-Aguilar A, Jiménez-Quintero A, Díaz-Alba A, Macías-Arriaga G, Cacho-Díaz B, Reyes-Moreno I, Gutiérrez-Aceves GA, García-González U, Guerrero-Juárez V, Manuel de Jesús ER, Antonio-Heredia Á, Zertuche-Ortuño L, Soto GR, Hernández GH, Gutiérrez-Casillas S. PMID: 41942762 [PubMed - in process]
	CPX-351 (Liposomal Cytarabine and Daunorubicin) versus venetoclax plus hypomethylating agent therapy in newly diagnosed acute myeloid leukemia: a retrospective comparison involving 600 Mayo Clinic patients. Blood Cancer J Fathima S, Rokach L, Ghosoun N, Rezasoltani M, Ilyas R, Alsugair A, McCullough K, Abdelmagid M, Al-Kali A, Alkhateeb HB, Begna KH, Mangaonkar AA, Matin A, Saliba AN, Hefazi Torghabeh M, Litzow MR, Hogan W, Shah M, Patnaik MM, Pardanani A, Badar T, Murthy H, Foran J, Palmer J, Punwani N, Sproat L, Khera N, Arana Yi C, Tefferi A, Gangat N. PMID: 41942467 [PubMed - as supplied by publisher]
	Loncastuximab Tesirine in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Evidence and Practical Guidance From Italian Clinical Experience. Eur J Haematol Bonello F, Aroldi A, Castellino A, Mannelli L, Boccellato E, Rosati S, Verga L, Vitolo U. PMID: 41942142 [PubMed - as supplied by publisher]
	First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in Leukemia. J Clin Oncol Rettinger E, Heckl D, Hutter M, Salzmann-Manrique E, Luedtke M, Huenecke S, Bremm M, Cappel C, Bug G, Greil J, Meisel R, Wagner-Drouet EM, Serve H, Güngör T, Klusmann JH, Klingebiel T, Bader P, Bonig H. PMID: 41941697 [PubMed - as supplied by publisher]
	Phase 1 Study of KITE-222, an Autologous CLL-1-directed CAR T-cell Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia. Clin Cancer Res Daver N, Blachly JS, Ghobadi A, Advani A, Muffly L, Garciaz S, Recher C, Kahali B, Sun J, Jung AS, Filosto S, Mao D, Granados E, Sallman DA. PMID: 41941266 [PubMed - as supplied by publisher]
	Efficacy and safety of zanubrutinib and camrelizumab combined with CD19 chimeric antigen receptor T-cell in the treatment of relapsed/refractory diffuse large B-cell lymphoma. Front Immunol Zhang H, He X, Xiao X, Ly H, Zhao M. PMID: 41939901 [PubMed - indexed for MEDLINE]
	Prognostic factors in SÃ©zary syndrome - a retrospective propensity score-matched study on 1277 patients. Front Immunol Ninosu N, Kappenstein M, Gebauer N, von Bubnoff D, von Bubnoff N, Nicolay JP. PMID: 41939895 [PubMed - indexed for MEDLINE]
	Correction to "Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma treated with anti-CD19 CAR-T cells: CARTHYM, a study from the French national DESCAR-T registry". Hemasphere PMID: 41939252 [PubMed]

Articles 1 - 20 / 166983

Page 1 of 8350



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy